Roles and Mechanisms of Irisin in Attenuating Pathological Features of Osteoarthritis
Open Access
- 28 September 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 9
Abstract
To investigate the effects and mechanisms of irisin, a newly discovered myokine, in cartilage development, osteoarthritis (OA) pathophysiology and its therapeutic potential for treating OA we applied the following five strategical analyses using (1) murine joint tissues at different developmental stages; (2) human normal and OA pathological tissue samples; (3) experimental OA mouse model; (4) irisin gene knockout (KO) and knock in (KI) mouse lines and their cartilage cells; (5) in vitro mechanistic experiments. We found that Irisin was involved in all stages of cartilage development. Both human and mouse OA tissues showed a decreased expression of irisin. Intra-articular injection of irisin attenuated ACLT-induced OA progression. Irisin knockout mice developed severe OA while irisin overexpression in both irisin KI mice and intraarticular injection of irisin protein attenuated OA progression. Irisin inhibited inflammation and promoted anabolism in chondrogenic ADTC5 cells. Proliferative potential of primary chondrocytes from KI mice was found to be enhanced, while KO mice showed an inhibition under normal or inflammatory conditions. The primary chondrocytes from irisin KI mice showed reduced expression of inflammatory factors and the chondrocytes isolated from KO mice showed an opposite pattern. In conclusion, it is the first time to show that irisin is involved in cartilage development and OA pathogenesis. Irisin has the potential to ameliorate OA progression by decreasing cartilage degradation and inhibiting inflammation, which could lead to the development of a novel therapeutic target for treating bone and cartilage disorders including osteoarthritis.Keywords
Funding Information
- National Institutes of Health (DE25681, DE26507, DE25020, AR54620, AR62207)
- American Heart Association (19AIREA34380849)
- New Jersey Health Foundation (ISFP 18-19)
This publication has 35 references indexed in Scilit:
- Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbitsActa Biomaterialia, 2012
- A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesisNature, 2012
- Enhanced osseointegration of titanium implant through the local delivery of transcription factor SATB2Biomaterials, 2011
- Roles of SATB2 in Osteogenic Differentiation and Bone RegenerationTissue Engineering Part A, 2011
- Effects of miR-335-5p in modulating osteogenic differentiation by specifically downregulating Wnt antagonist DKK1Journal of Bone and Mineral Research, 2011
- Overexpression of Bone Sialoprotein Leads to an Uncoupling of Bone Formation and Bone Resorption in MiceJournal of Bone and Mineral Research, 2008
- Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulinOsteoarthritis and Cartilage, 2008
- Primary culture and phenotyping of murine chondrocytesNature Protocols, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Radiological Assessment of Osteo-ArthrosisAnnals of the Rheumatic Diseases, 1957